The Venture Codex Logo

The Venture Codex

Loyal Valley Capital

1/F, No.11 Building, No.1257 Mingyue Road, Pudong, Shanghai, 201206, China

Overview

Thematic private equity firm investing in middle market companies in China.

Founded

2015

Deals · 12mo

3

Links

WebsiteLinkedIn

Stage focus

Series B
Series C

Geographic focus

China
Hong Kong
Russian Federation
United States

Sector focus

Asset Management
Finance
Financial Services
Venture Capital

Investment portfolio

18rounds
NAMEDATESIZE
Vivacta Biotechnology (Shanghai) Co., Ltd.
Apr 2026Led
$50 MSeries A
Galaxea AI
Feb 2026Participated
$145 MSeries B
Surgerii Robotics
Jan 2026Led
$100 MOther Equity
Sinovent
Feb 2024Participated
$97 MSeries E
DP Technology
Aug 2023Led
$100 MOther Equity
Medilink Therapeutics
Mar 2022Participated
$70 MSeries B
Sciwind Biosciences
Oct 2021Led
$70 MSeries C
Hepagene Therapeutics
Apr 2021Led
$40 MSeries B
EdiGene
Apr 2021Led
$62 MSeries B
Arctic Vision
Mar 2021Led
$100 MSeries B
Regor Therapeutics
Feb 2021Participated
$90 MSeries B
CARsgen Therapeutics
Nov 2020Led
$186 MSeries C
Vivacta Biotechnology (Shanghai) Co., Ltd.
Apr 2026Led
$50 MSeries A
Galaxea AI
Feb 2026Participated
$145 MSeries B
Surgerii Robotics
Jan 2026Led
$100 MOther Equity
Sinovent
Feb 2024Participated
$97 MSeries E
DP Technology
Aug 2023Led
$100 MOther Equity
Medilink Therapeutics
Mar 2022Participated
$70 MSeries B
Sciwind Biosciences
Oct 2021Led
$70 MSeries C
Hepagene Therapeutics
Apr 2021Led
$40 MSeries B
EdiGene
Apr 2021Led
$62 MSeries B
Arctic Vision
Mar 2021Led
$100 MSeries B
Regor Therapeutics
Feb 2021Participated
$90 MSeries B
CARsgen Therapeutics
Nov 2020Led
$186 MSeries C
18
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Loyal Valley Capital: 18 funding rounds are recorded in the selected participation categories.All available history.
Loyal Valley Capital: 18 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A10
Series B43
Series C+43
Other Equity21

Monthly Deal Activity

Loyal Valley Capital: 18 deals are recorded across 97 months.All available history.
Loyal Valley Capital: 18 deals are recorded across 97 months. All available history
MonthDeals
Oct '181
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '191
Dec '190
Jan '200
Feb '201
Mar '200
Apr '201
May '200
Jun '200
Jul '200
Aug '200
Sep '201
Oct '201
Nov '201
Dec '200
Jan '210
Feb '211
Mar '211
Apr '212
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '211
Nov '210
Dec '210
Jan '220
Feb '220
Mar '221
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '231
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '241
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '261
Feb '261
Mar '260
Apr '261
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Loyal Valley Capital: Health & Life Sciences is the largest displayed sector by deal count (15 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Loyal Valley Capital: Health & Life Sciences is the largest displayed sector by deal count (15 deals). All available history
SectorDeals
Health & Life Sciences15
Hardware & Robotics2
Fintech2
Manufacturing2
AI & Machine Learning2
Space & Frontier Tech2
Education & Workforce1
Media & Entertainment1
Transportation & Logistics1
Consumer & Lifestyle1

Deal Size Distribution

Loyal Valley Capital: 18 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Loyal Valley Capital: 18 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M2
$50M-$100M7
$100M-$250M9
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Loyal Valley Capital: China has the largest recorded deal count among the displayed regions (15 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

Loyal Valley Capital: China has the largest recorded deal count among the displayed regions (15 deals). All available history
RegionDeals
China15
Hong Kong1
Russian Federation1
United States1
Loyal Valley Capital: 20 co-investors are shown, with Lilly Asia Ventures sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Loyal Valley Capital: 20 co-investors are shown, with Lilly Asia Ventures sharing 4 recorded deals. All available history
Co-investorShared deals
Lilly Asia Ventures4
OrbiMed4
Tencent3
Apricot Capital2
Hillhouse Capital2
IDG Capital2
Lake Bleu Capital2
LYFE Capital2
Qiming Venture Partners2
Sherpa Healthcare Partners2
3H Health Investment1
AIHC Capital1
BAI Capital1
Capital Today1
Cathay Capital1
CDG International1
China Oceanwide Capital1
CITIC Capital1
Coyote Ventures1
Decheng Capital1

Investment Strategy

Loyal Valley Capital: Led accounts for 61% and participating for 39% of round participation.All available history.
Loyal Valley Capital: Led accounts for 61% and participating for 39% of round participation. All available history
CategoryDeals (count)Share (%)
Led1161%
Participating739%
Loyal Valley Capital: Single-lead accounts for 55% and co-led for 45% of lead dynamics.All available history.
Loyal Valley Capital: Single-lead accounts for 55% and co-led for 45% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead655%
Co-led545%

Team

Andy Lin

Founding Partner

Chengbin Li

Partner

Jason Zhao

Managing Director

Jay Gu

Managing Director

Linda Cai

Partner

Lisa Ye

Partner

Roy Xie

Managing Director and Head of Healthcare Investments

Yang Yi

Executive Director